SCHEDULE: Vanguard Reports 0% Orthofix Stake Post-Realignment
Beneficial Ownership Amendment
The Vanguard Group has updated its beneficial ownership in Orthofix Medical Inc. to 0% following an internal corporate realignment.
Summary
- The Vanguard Group, Inc. filed an Amendment No. 7 to Schedule 13G regarding its beneficial ownership of Common Stock in Orthofix Medical Inc.
- As of March 13, 2026, The Vanguard Group reported 0.00 shares beneficially owned, representing 0% of the class of securities.
- This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions of Vanguard will now report beneficial ownership separately (on a disaggregated basis).
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. It is an administrative update reflecting an internal organizational change at Vanguard, not a change in investment strategy or performance for Orthofix Medical Inc.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding Orthofix Medical Inc.'s operations or financial performance.
Industry Context
StockSavvy.ai notes that large institutional investors like The Vanguard Group periodically undergo internal restructurings or changes in reporting methodologies. This filing reflects an administrative change in how Vanguard's beneficial ownership is aggregated and reported, rather than a strategic investment decision regarding Orthofix Medical Inc. It highlights the complexity of beneficial ownership reporting for diversified asset managers.
Stakeholder Impact
- Shareholders of Orthofix Medical Inc. will see The Vanguard Group's reported beneficial ownership drop to 0%, but this does not necessarily indicate a divestment of shares by Vanguard's underlying funds, which will now report separately.
- The change primarily impacts how Vanguard's holdings are aggregated and disclosed, rather than the actual investment positions.
Key Dates
| Date | Description |
|---|---|
| 01/12/2026 | The Vanguard Group, Inc. underwent an internal realignment, leading to disaggregated beneficial ownership reporting. |
| 03/13/2026 | Date of event which required the filing of this Schedule 13G amendment. |
| 03/27/2026 | Date the Schedule 13G amendment was signed by The Vanguard Group. |
Keywords
Vanguard Group, Orthofix Medical Inc, Schedule 13G, beneficial ownership, internal realignment, institutional investor, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.